Association of High miR-182 Levels with Low-Risk Prostate Cancer-Reference-Cited by-同舟云学术

Association of High miR-182 Levels with Low-Risk Prostate Cancer

Published:2019-04 Issue:4 Volume:189 Page:911-923
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Baumann Bethany^ORCID,Acosta Andrés M.,Richards Zachary,Deaton Ryan,Sapatynska Anastasiya,Murphy Adam^ORCID,Kajdacsy-Balla Andre,Gann Peter H.,Nonn Larisa^ORCID

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference63 articles.

1. Cancer statistics, 2018;Siegel;CA Cancer J Clin,2018

2. Quality of life outcomes after primary treatment for clinically localised prostate cancer: a systematic review;Lardas;Eur Urol,2017

3. The University of California, San Francisco cancer of the prostate risk assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy;Cooperberg;J Urol,2005

4. NCCN guidelines insights: prostate cancer early detection, version 2.2016;Carroll;J Natl Compr Canc Netw,2016

5. A biopsy-based 17-gene genomic prostate score predicts recurrence after radical prostatectomy and adverse surgical pathology in a racially diverse population of men with clinically low- and intermediate-risk prostate cancer;Cullen;Eur Urol,2015

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in the preparation of microneedle patches for interstitial fluid extraction and analysis;Microchemical Journal;2023-12

2. Potential of miRNAs in Plasma Extracellular Vesicle for the Stratification of Prostate Cancer in a South African Population;Cancers;2023-08-04

3. Small Non-Coding RNAs in Human Cancer;Genes;2022-11-09

4. The Potential of MicroRNAs as Non-Invasive Prostate Cancer Biomarkers: A Systematic Literature Review Based on a Machine Learning Approach;Cancers;2022-11-03

5. MiR-223-3p attenuates the migration and invasion of NSCLC cells by regulating NLRP3;Frontiers in Oncology;2022-10-06